Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

Mohamed A. Kharfan-Dabaja, Michael D. Jain, Sonikpreet Aulakh, Ernesto Ayala, Abba C. Zubair, Han W. Tun, Hien D. Liu, Frederick L. Locke, Julio C. Chavez

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells'. Together they form a unique fingerprint.